Albireo
A biotechnology company, develops therapeutic drugs for gastrointestinal diseases. Learn more
Launch date
Employees
Market cap
€833m
Enterprise valuation
€677m (Public information from Mar 2023)
Share price
$44.15 ALBO
Boston Massachusetts (HQ)
Authorizing premium user...